Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See
full details
.
I Agree
×
Join today and have your say! It’s FREE!
Join Now
Sign In
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Join Today
or
Sign in with existing account
Privacy Policy
|
Disclaimer
Sign In
Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Remember me
Forgot Password?
Sign In
or
Sign Up
Privacy Policy
|
Disclaimer
Please Try Again
{{ error }}
Send my password
Submit
Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Linking with Facebook:
Stockhouse membership requires an email address which must be shared by Facebook.
By default, joining or signing in using your Facebook account will work and the email address will be shared by Facebook automatically.
If you change your Facebook permissions to restrict Stockhouse from receiving your email while joining or signing in to Stockhouse then it will fail.
Please do not modify the permission settings during sign-in.
Sign in with Facebook
Return to Signup Options
Home
Community
Bullboards
Blogs
Groups
Messages
Markets
Stocks
TSX
TSXV
CSE
NASDAQ
NYSE
NYSE American
Cryptocurrency
Currencies
Commodities
Market Movers
Bonds
News
Featured News
Trending News
Canadian Press Releases
US Press Releases
Video
Editorial
Independent Reports
Interviews
Buzz on the Bullboards
Portfolio
Watchlist
Portfolio
Real Time & Level II Data
Showcase Companies
DealRoom
News Focus
Private Placement: Ready for a Golden Opportunity in Ghana and Canada? (click to learn more)
Quote
|
Bullboard
|
News
|
Opinion
|
Profile
|
Peers
|
Filings
|
Financials
|
Options
|
Price History
|
Ratios
|
Ownership
|
Insiders
|
Valuation
Bullboard - Stock Discussion Forum
Enzo Biochem Inc
ENZ
Healthcare
Enzo Biochem, Inc. is engaged in the product development to support a diverse range of needs in biomedical research and healthcare. The Company’s comprehensive portfolio products including antibodies, genomic probes, assays, biochemicals, and proteins. The Company operates through one segment: Products. The Company’s Products segment develops, manufactures, and markets products to research and...
pharmaceutical customers. It manufactures, develops and markets products and tools for clinical research, drug development and bioscience research customers worldwide. Its subsidiary, Enzo Life Sciences, has developed proprietary products used in the identification of genomic information by laboratories around the world. Its operations are supported by global operations allowing for the efficient marketing and delivery of its products around the world.
see more
Join the community and start posting on the bullboards today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Create a portfolio watchlist today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Add To Watchlist
Bullboard (NYSE:ENZ)
New Post
View:
Posts & Comments
Threaded Posts
(0)
•••
johnson021
X
Post by
johnson021
on Sep 12, 2022 1:00am
Uveitis Treatment Market Trends, Demand And Size 2022-27
According to the latest report by IMARC Group, titled “Uveitis Treatment Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2022-2027″ Offers a comprehensive analysis of the
...more
(1)
•••
edwardebreen15
X
Post by
edwardebreen15
on Aug 23, 2022 1:11am
Nucleic Acid Labelling Market Analysis & Forecast 2021-26
According to IMARC Group’s latest report, titled “Nucleic Acid Labelling Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2021-2026” the global market grew at a CAGR of
...more
Thank You
Your Report has been submitted.
Report Abusive Content
×
Sign up to get access
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
The Market Update
{{currentVideo.title}}
{{currentVideo.relativeTime}}
{{currentVideo.storiesTitle}}:
{{story.companySymbol}}
{{story.companySymbol}}
{{story.headline}}
< Previous bulletin
Next bulletin >
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}
{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >
Featured News Links
Criminal syndicate allegedly infiltrated Barrick Gold subsidiary
Nickel Miner Announces a Battery Supply Chain MOU with “PPES”, a JV Between Toyota and Panasonic
Electric Dreams: Transforming the World with a Clean Energy Future - Download Free Report Now!